Findings based on 15-year follow-up study conducted among veterans with type 2 diabetes

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Exercise, Therapy …

Decline in NLEA among patients with end-stage renal disease with diabetes stabilized since 2013

Exercise and cognitive behavioral therapy can improve depression outcomes in adults with type 2 diabetes

Correlation not affected by adjustment for cardiovascular disease, end-stage renal disease

Following increase from 1990 to 2007, incidence rates significantly decreased since 2007

Two modifiable variables potentially explain more than half of all atrioventricular blocks

Only 1 percent of veterans enrolled in weight management programs receive medications

Correlation independent of major covariates including anthropometric factors and diabetes duration

In multivariate analysis, age, albumin concentration, T2DM independently tied to progression